Disposable gloves market was valued at $15.5 billion in 2025 and is projected to reach $27.3 billion by 2035, growing at a CAGR of 5.80% during the forecast period (2026–2035). Market growth is primarily driven by increasing healthcare safety standards and infection prevention practices globally. According to the World Health Organization emphasized that, medical gloves are essential for infection prevention but do not replace proper hand hygiene practices. The organization highlighted that improper or excessive glove use can increase contamination risks and contribute to healthcare waste. WHO further noted that nearly 2 in 5 healthcare facilities lack basic hand hygiene services, reinforcing the need for balanced glove usage and hygiene protocols. Additionally, rising industrial safety regulations across manufacturing and food processing sectors are further accelerating adoption.

Dental cement market was valued at $1.0 billion in 2025 and is projected to reach $1.7 billion by 2035, registering a CAGR of 5.80% during the forecast period from 2026 to 2035. Market growth is primarily driven by the increasing prevalence of oral diseases worldwide. According to the World Health Organization, oral diseases affect approximately 3.7 billion people globally, with untreated dental caries being the most common condition. The high cost and limited accessibility of dental care, particularly in low- and middle-income countries, continue to pose significant challenges. This scenario is accelerating the demand for effective and affordable restorative dental solutions, including dental cements. Furthermore, the rising number of dental visits and growing adoption of prosthodontic procedures are supporting market expansion. Increased awareness of oral health and advancements in dental materials are also contributing to sustained growth across both developed and emerging markets.

Corporate assessment service market is expected to expand from $3.8 billion in 2025 to $10.1 billion by 2035, growing at a CAGR of 10.2% during 2026–2035. This growth is primarily driven by the increasing adoption of AI-powered hiring solutions and ongoing digital workforce transformation. In November 2024, the International Telecommunication Union reported that around 5.5 billion people (68% of the global population) were using the internet, marking an increase of 227 million users from 2023. Despite this progress, approximately 2.6 billion people remain offline, highlighting persistent digital disparities. Rising internet penetration is significantly boosting the adoption of digital platforms, including AI-driven recruitment and corporate assessment tools. This trend is accelerating the shift toward remote hiring, online testing, and workforce analytics solutions. As global connectivity continues to improve, it is expected to further enhance the scalability and effectiveness of data-driven talent assessment platforms.

Connected ship market was valued at $5.4 billion in 2025 and is expected to reach $10.1 billion by 2035, expanding at a CAGR of 6.6% during the forecast period from 2026 to 2035. The market is expanding due to the increasing digitalization of maritime operations and the rising need for real-time monitoring and operational efficiency. According to the International Telecommunication Union (ITU), global internet users reached 6 billion people, representing around 75% of the population, with more than 240 million new users added in 2025. Additionally, 5G coverage has expanded to approximately 55% of the global population, reflecting rapid advancements in connectivity infrastructure. This growth in global connectivity is indirectly accelerating the adoption of connected ship technologies, particularly satellite communication systems and IoT-enabled solutions. These technologies enable seamless data exchange, improved navigation, and enhanced fleet management capabilities. Furthermore, the growing emphasis on fuel efficiency, regulatory compliance, and predictive maintenance is driving investments in advanced maritime digital solutions. As a result, connected ship technologies are becoming increasingly essential across global maritime industries.

Companion diagnostics market was valued at $5.5 billion in 2025 and is projected to reach $14.7 billion by 2035, growing at a CAGR of 10.5% from 2026 to 2035. The market is expanding due to the increasing adoption of precision medicine and targeted therapeutic approaches. According to the Personalized Medicine Coalition, its Personalized Medicine at FDA 2024 report highlights that a substantial proportion of newly approved drugs are personalized therapies that rely on biomarker-based testing. In 2024, personalized medicines accounted for nearly 38% of all FDA approvals, reflecting a strong shift toward individualized treatment strategies. This growing dependence on biomarker-driven therapies is significantly increasing the demand for companion diagnostics. Additionally, the rising use of next-generation sequencing (NGS) technologies is enhancing the accuracy of disease detection and treatment selection. These advancements are improving clinical outcomes while supporting broader adoption of precision diagnostics across healthcare systems.

Colorectal cancer drugs market was valued at $12.3 billion in 2025 and is projected to reach $25.4 billion by 2035, growing at a CAGR of 7.6%. This growth is largely driven by the increasing global burden of colorectal cancer, which remains one of the most prevalent and life-threatening malignancies worldwide. Rising incidence rates, particularly among aging populations and in developing economies, are accelerating the demand for effective treatment solutions. Lifestyle-related risk factors such as unhealthy diets, physical inactivity, smoking, and increasing obesity levels are contributing to the growing prevalence of colorectal cancer. As a result, there is a strong shift toward advanced treatment approaches, including targeted therapies and immunotherapies. These therapies offer improved precision, enhanced efficacy, and better patient outcomes compared to conventional chemotherapy, making them increasingly preferred in clinical practice.

Collective intelligence platform market was valued at $769.0 million in 2025 and is projected to reach $2,725.0 million by 2035, growing at a robust CAGR of 13.6% between 2026 and 2035. This growth is largely driven by the increasing adoption of AI-powered decision-making tools across enterprises. In November 2025, the International Telecommunication Union (ITU) reported that global internet users reached around 6 billion, accounting for nearly three-quarters of the global population, with over 240 million new users added within a year. The rapid rise in digital connectivity is significantly boosting data generation and enabling large-scale online collaboration. These developments are creating a strong foundation for collective intelligence platforms that depend on both human input and machine-driven insights. Furthermore, the ITU highlighted the growing importance of digital infrastructure and advanced AI technologies in supporting this expansion. As digital participation continues to rise, the demand for collective intelligence platforms is accelerating across key sectors such as BFSI, healthcare, and government.

Cell counting market was valued at $10.2 billion in 2025 and is projected to reach $22.2 billion by 2035, growing at a CAGR of 8.1% from 2026 to 2035. Growth is driven by rising adoption of biopharmaceutical production, clinical diagnostics, and cell-based research workflows. Increasing demand for precision medicine and biologics manufacturing is further boosting the need for accurate and automated cell counting technologies. According to the India BioEconomy Report 2026 published by DBT, BIRAC, and ABLE, India’s biotechnology ecosystem is expanding rapidly, particularly in biopharma, diagnostics, and life sciences R&D. The report highlights growing investments in biotechnology-enabled healthcare infrastructure, laboratories, and clinical development platforms. This expansion is expected to accelerate demand for advanced analytical tools used in cell-based research and bioprocessing. Overall, the strengthening bioeconomy in India supports long-term growth in the cell counting and related life science tools market.

Cardiovascular devices market was valued at $72.0 billion in 2025 and is projected to reach $131.0 billion by 2035, growing at a CAGR of 6.20% during the forecast period (2026–2035). Market growth is driven by the increasing burden of cardiovascular diseases and rising adoption of advanced medical technologies. According to the World Health Organization (WHO), cardiovascular diseases remain the leading cause of death globally, accounting for nearly 19.8 million casualties annually, or about 32% of total global casualties. This growing disease burden is significantly increasing demand for interventional cardiology devices, cardiac rhythm management systems, and structural heart solutions across healthcare systems globally. Additionally, expanding access to minimally invasive procedures and implantable cardiac technologies is improving patient outcomes and supporting market expansion.

Cardiac arrest treatment market was valued at $13.5 billion in 2025 and is projected to reach $23.0 billion by 2035, expanding at a CAGR of 5.8% during the forecast period. Market growth is primarily driven by the rising incidence of sudden cardiac arrest and increasing deployment of emergency response infrastructure. According to the World Health Organization, cardiovascular diseases account for nearly 17.9 million deaths annually, with a significant portion linked to sudden cardiac arrest. This growing burden is increasing demand for defibrillators, emergency drugs, and ICU-based post-arrest care. Additionally, the expansion of emergency medical services (EMS) and public access defibrillation programs is strengthening treatment accessibility across both developed and emerging regions.